Tau PET Imaging in Atypical Dementias

• Status: Recruiting
• Trial end date: 2023-02-01
• Target enrollment: 0
• Participant gender: All

Summary

The goal of this study is to demonstrate the feasibility of mapping tau pathology in subjects with Primary Progressive Aphasia, using PET protocol with F-AV-1451 (trade name AV-1451) and to systematically document the extent and location of tau pathology in PPA patients in vivo using the same techniques.

• Phase: Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Northwestern University
• Collaborator: National Institute on Aging (NIA)

Criteria

Inclusion Criteria:

• Must have primary progressive aphasia

Exclusion Criteria:

• Pregnancy

• Breastfeeding

• Receiving radiation clinically